Macrocycles for Drug Discovery

MSCA (Marie Skłodowska-Curie)HORIZON-TMA-MSCA-DNID: 101168916
EC Contribution
€32,708
Consortium Size
20 orgs
Start Year
2024
Summary

Better drugs are one of the most efficient and sustainable ways to improve health care, a key strategic orientation in Horizon Europe.New drug modalities such as macrocycles are expected to be a key enabling technology for this strategic perspective. The goal of MC4DD is to train the next generation of European medicinal chemists in a multidisciplinary environment to promote European drug discovery competitiveness, directly by advancing knowhow on macrocycles and long-term via the skills carried on by the researchers trained in the doctoral network.

Consortium (20)